{
  "studyTitle": "Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.",
  "yearofPublication": "2023",
  "author": "Laure F Pittet et al.",
  "studySample": "3986",
  "comparisonGroups": [
    "bcg-denmark vaccine",
    "saline placebo"
  ],
  "blinding": "Double-blind",
  "primaryOutcome": "Symptomatic Covid-19 and severe Covid-19 at 6 months",
  "primaryOutcomeResults": "Risk of symptomatic Covid-19 by 6 months was 14.7% in the BCG group and 12.3% in the placebo group (risk difference, 2.4 percentage points; 95% CI, -0.7 to 5.5; P = 0.13). Risk of severe Covid-19 by 6 months was 7.6% in the BCG group and 6.5% in the placebo group (risk difference, 1.1 percentage points; 95% CI, -1.2 to 3.5; P = 0.34).",
  "conclusion": "Vaccination with BCG-Denmark did not result in a lower risk of Covid-19 among health care workers than placebo.",
  "gPTSummary": "This double-blind international study of 3986 health care workers found that vaccination with BCG-Denmark did not result in a lower risk of Covid-19 than placebo, with a risk of symptomatic Covid-19 by 6 months of 14.7% in the BCG group and 12.3% in the placebo group (risk difference, 2.4 percentage points; 95% CI, -0.7 to 5.5; P = 0.13). Risk of severe Covid-19 by 6 months was 7.6% in the BCG group and 6.5% in the placebo group (risk difference, 1.1 percentage points; 95% CI, -1.2 to 3.5; P = 0.34).",
  "studyURL": "https://pubmed.ncbi.nlm.nih.gov/pubmed/37099341"
}